BioSpace News Archive

The agreement provides argenx access to Elektrofi’s breakthrough high-concentration, low-volume delivery technology for the development of therapeutic products

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2021 financial results before the stock market opens on Tuesday, May 4, 2021, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time

Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the first patient was enrolled in the Frontier V study, a European multicenter study evaluating PerQseal®+, the next generation of the company’s PerQseal® device.

Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced three key appointments to its Board of Directors: Meryl Zausner, former U.S. Senator William “Mo” Cowan and Tyrell Rivers, Ph.D. Ms. Zausner will also serve as Chair of the company’s Audit Committee.

More than 14 abstracts, including new findings from Incyte’s clinical trial programs for ruxolitinib cream in patients with vitiligo and atopic dermatitis, to be presented

Partnership Leverages Lineage’s Investigational VAC Allogeneic Cancer Vaccine Platform and Immunomic’s Proprietary Tumor Associated Antigen to Generate a Novel Oncology Product Candidate

Ripple Therapeutics Corporation a clinical stage, ophthalmology-focused developer of novel pharmaceuticals, announced today that the first patient has been treated in RIPPLE-1, a Phase II trial evaluating IBE-814 IVT, a proprietary intravitreal dexamethasone implant targeting inflammatory retinal diseases.

Thermal Energy International Inc. (TSX.V:TMG) , an innovative cleantech company and global provider of energy efficiency and emissions reduction solutions, today announced that it will be presenting at the Planet MicroCap Showcase: VIRTUAL on April, 21 at 10:30 AM EST.

MagicMed Industries Inc. a biotechnology company focused on creating novel psychedelic derivative molecules, today announced that Dr. Joseph Tucker, President and Chief Executive Officer, will be presenting a business and pipeline update at the LifeSciencesInvestorForum.com on April 22 nd , 2021 as follows: DATE: Thursday, April 22 nd , 2021. TIME: 2:00PM EST

Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 third quarter financial results after the market closes on Thursday, May 6, 2021.